Navigation Links
New vaccine protects more effectively against tuberculosis

Max Planck researchers uncover the mechanism by which the new genetically engineered vaccine functionsThe vaccine has been licensed to the Vakzine Projekt Management who will test it in clinical trials early 2006. The responsible mechanisms for the high efficacy of this vaccine has now been deciphered (Journal of Clinical Investigations, August 18, 2005).

Globally, tuberculosis remains the number one killer in adults. Moreover, multi-drug-resistant tuberculosis strains are on the rise which cannot be treated by first-line drugs. A vaccine against tuberculosis, termed BCG is available which, however, fails to protect against the most frequent form of disease, pulmonary tuberculosis in adults. A more efficient vaccine is urgently needed for control of this global threat.

Recombinant BCG, which express listeriolysin and is deleted for the urease gene, has been created and shown to stimulate far more efficacious protection against tuberculosis than the BCG vaccine currently in use. This new vaccine induces cell death in infected host cells, which leads to stimulation of protection by dendritic cells, the most efficacious antigen-presenting cells. As a result, stronger protection against pulmonary tuberculosis has been achieved in preclinical studies. Importantly, the new vaccine also protects against clinical isolates of the Beijing family. These clinical isolates are frequently multi-drug-resistant and more aggressive and hence have started to conquer the globe. It has been assumed that the Beijing isolates emerged in response to drug treatment and vaccination. The new genetically engineered BCG could provide an efficacious measure against this threat.


'"/>

Source:Max-Planck-Gesellschaft


Page: 1

Related biology news :

1. Research advances quest for HIV-1 vaccine
2. A much-needed shot in the arm for HIV vaccine development
3. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
4. Gene vaccine for Alzheimers disease shows promising results
5. Influenza vaccine uses insect cells to speed development
6. Norovirus, AIDS vaccine and Hepatitis Virus
7. HIV vaccine trial breaks ground for future research
8. Live vaccines more effective against horse herpes virus
9. NIAID begins clinical trial of West Nile virus vaccine
10. Designing vaccines by computer
11. Wake Forest scientists find new combination vaccine effective against plague

Post Your Comments:
(Date:11/4/2009)...6 BIO-key International,...er-based biometric identification software is show... AABB TXPO conference being held at the New Orlean...ey will provide hands-on product demonstrations of... booth #424. Also, at 5 PM on Monday, October 26, ...
(Date:11/3/2009)... 4, 2009 -- The world,s greatest wines are the re...uman input, and something called the "terroir" -- ...nd climate. , Experts will discuss terroir wit...dnesday, Nov. 4 in Pittsburgh. "Terroir: Winegrap...arts at the 2009 Annual Meetings of the American S...
(Date:11/3/2009)...bese women are as much as 28 percent less likely t... according to research that earned a Michigan Stat...indings by Barbara Luke, a researcher in the MSU C...s, Gynecology and Reproductive Biology, focused on...uctive technology. , Luke,s findings, which also...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Great wines come from great soils 2MSU researcher: Obesity significantly cuts odds of successful pregnancy 2AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting 5506 1Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 5502 1Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 5502 2Green Spaces Boost the Body and the Mind 59520 1Green Spaces Boost the Body and the Mind 59520 2Green Spaces Boost the Body and the Mind 59520 3
...on from apes to humans may have been partially tri...to safely carry heavier babies. This theory1 of sp...niversity of So Paulo in Brazil has just been publ...ften. , For safety, all nonhuman primates carry t...pecies survival depends on it. The carrying patter...
...chnologies developed at the Department of Energy,s...sulfurization system and a fuel reforming system -...tric power system operating on JP-8, a fuel common...cell power units are quieter, more efficient and h...s, but are challenged when used with JP-8 fuel bec...
...studying ancient fish bones in Scandinavia have di...d black sea bream that ,once thrived in Danish wat...ning. Some cold-water species, such as cod, were a...from a lower fishing effort. , Through the study...registers and account books of monasteries, an int...
Other Biology News:Walking tall to protect the species 2Fuel cells help make noisy, hot generators a thing of the past 2Ancient fish bones reveal impacts of global warming beneath the sea 2Ancient fish bones reveal impacts of global warming beneath the sea 3Ancient fish bones reveal impacts of global warming beneath the sea 4Ancient fish bones reveal impacts of global warming beneath the sea 5
(Date:11/6/2009)...PRNewswire/ -- Myriant Technologies LLC ("Myriant"...turer of renewable bio-chemicals, Uhde Corporatio... Uhde GmbH, one of the world,s leading engineering...ce for the engineering, procurement & construc...nts based on renewable feedstocks. The execution ...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. deliv...S® continuous delivery of exenatide) program ...Annual Diabetes Technology Meeting in San Francisc...n/prnh/20050301/SFTU126LOGO ) ,, Continuous S...ers Plasma Glucose, HbA1c and Reduces Weight in a ...
(Date:11/5/2009)...5 DSM Pharmaceutical Products toda...nce with Galenix, Saint Jean D,Illac, France, wher...acturing partner for Galenix commercial products o...borate on business development opportunities co-ma...on the strength of Galenix in drug product develop...
(Date:11/5/2009)... BioSpecifics Technologie...any developing first-in-class collagenase-based pr...the third quarter ended September 30, 2009. ,,...is year, the FDA,s Arthritis Advisory Committee un...oval of XIAFLEX(TM) for the treatment of Dupuytren...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...ovember 11 Park Avenue Medical Data Systems,(PAMD...he electronic,healthcare record (EHR) arena, annou...ware-as-a-Service product (SaaS) that enables offi...ices, and specialized medical,facilities to earn p...rsuant to the CMS Physician Quality Reporting Init...
...ire Lead Discovery provides an easy-to-use, highly...chemical structures and any,associated data, SOME...q: TIBX ), today announced the release of TIBCO S...mists to quickly access chemistry and,biological d...build,best-practice applications for chemical stru...
...esented at the Meeting Demonstrate Vitamin E May H...tes, MONTVALE, N.J., Nov. 11 Synvista,Therapeuti...monstrating that,discontinuation of Vitamin E in p...ncreased risk of heart attack and rapid deteriorat...today at the Annual Scientific,Sessions of the Ame...
Other Biology Technology:PQRI Made Easy(TM): A New Software Enables Healthcare Professionals to Earn Their 2008 and 2009 PQRI Bonuses for Free 2TIBCO Speeds Drug Discovery for Chemists 2TIBCO Speeds Drug Discovery for Chemists 3Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting 2Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting 3Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting 4
Essential Data: Centrifugation from Promega
rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.
Rabbit anti-JLP AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Proteins LabFax from Promega
Biology Products: